It has demonstrated that CML patients with type 2 diabetes have markedly elevated levels of adiponectin, implicating a mechanism for improved insulin sensitivity in the peripheral tissues [9], [20]. Here, ADIPOQ is linked to type 2 diabetes mellitus.